As of 2025-04-20, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (311.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -129409.1%.
The range of the Relative Valuation is (291.90) - (461.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 23.0x | 14.0x |
| Forward P/E multiples | 11.8x - 20.0x | 13.0x |
| Fair Price | (291.90) - (461.87) | (311.76) |
| Upside | -121171.6% - -191669.0% | -129409.1% |
| Date | P/E |